F7G Stock Overview
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally.
Thorne HealthTech, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$5.90|
|52 Week High||US$6.70|
|52 Week Low||US$3.90|
|1 Month Change||30.53%|
|3 Month Change||-3.28%|
|1 Year Change||n/a|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||38.86%|
Recent News & Updates
|F7G||DE Personal Products||DE Market|
Return vs Industry: Insufficient data to determine how F7G performed against the German Personal Products industry.
Return vs Market: Insufficient data to determine how F7G performed against the German Market.
|F7G Average Weekly Movement||7.9%|
|Personal Products Industry Average Movement||5.4%|
|Market Average Movement||5.7%|
|10% most volatile stocks in DE Market||10.7%|
|10% least volatile stocks in DE Market||2.8%|
Stable Share Price: F7G is more volatile than 75% of German stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: F7G's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual’s health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health.
Thorne HealthTech, Inc. Fundamentals Summary
|F7G fundamental statistics|
Is F7G overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|F7G income statement (TTM)|
|Cost of Revenue||US$91.20m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
Aug 09, 2022
|Earnings per share (EPS)||0.17|
|Net Profit Margin||4.46%|
How did F7G perform over the long term?See historical performance and comparison